Patents by Inventor Kevin Cusack

Kevin Cusack has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HETEROCYCLIC KINASE INHIBITORS
    Publication number: 20190135836
    Abstract: This invention provides compounds of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers, and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
    Type: Application
    Filed: December 21, 2018
    Publication date: May 9, 2019
    Inventors: Michael Friedman, Phil Cox, Kristine E. Frank, Michael Z. Hoemann, Augustine Osuma, Noel S. Wilson, Xiangdong Xu, Kevin Cusack, Raymond Huntley, J. Martin Herold
  • Heterocyclic kinase inhibitors
    Patent number: 10280184
    Abstract: The invention provides compounds of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
    Type: Grant
    Filed: April 16, 2015
    Date of Patent: May 7, 2019
    Assignee: AbbVie Inc.
    Inventors: Michael M. Friedman, Philip Cox, Kristine E. Frank, Michael Z. Hoemann, Augustine Osuma, Noel S. Wilson, Xiangdong Xu, Kevin Cusack, Raymond Huntley, J. Martin Herold
  • HETEROCYCLIC KINASE INHIBITORS
    Publication number: 20170114077
    Abstract: The invention provides compounds of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
    Type: Application
    Filed: April 16, 2015
    Publication date: April 27, 2017
    Inventors: Michael M. FRIDEMAN, Philip COX, Kristine E. FRANK, Michael Z. HOEMANN, Augustine OSUMA, Noel S. WILSON, Xiangdong XU, Kevin CUSACK, Raymond HUNTLEY, J. Martin HEROLD
  • Indazole compounds
    Publication number: 20070282101
    Abstract: Novel compounds of Formula (I) or pharmaceutically acceptable salts, prodrugs and biologically active metabolites thereof of Formula (I) wherein the substituents are as defined herein, which are useful as therapeutic agents.
    Type: Application
    Filed: April 2, 2007
    Publication date: December 6, 2007
    Inventors: Anna Ericsson, Andrew Burchat, Kristine Frank, David Calderwood, Lily Abbott, Maria Argiriadi, David Borhani, Kevin Cusack, Richard Dixon, Thomas Gordon, Kelly Mullen, Robert Talanian, Xiaoyun Wu, Xiaolei Zhang, Lu Wang, Biqin Li, Claude Barberis, Neil Wishart
  • Kinase inhibitors as therapeutic agents
    Publication number: 20060074102
    Abstract: A compound or pharmaceutically acceptable salts thereof of Formula (I) wherein the substituents are as defined herein, which are useful as kinase inhibitors.
    Type: Application
    Filed: May 13, 2005
    Publication date: April 6, 2006
    Inventors: Kevin Cusack, Jose-Andres Salmeron-Garcia, Thomas Gordon, Claude Barberis, Hamish Allen, Agniezka Bischoff, Anna Ericsson, Michael Friedman, Dawn George, Gregory Roth, Robert Talanian, Christine Thomas, Grier Wallace, Neil Wishart, Zhengtian Yu